Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Mpsyf crawled date : 2022 - 10 - 27 save search
GSK, MorphoSys' Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: -3.82%
H: 6.9%
C: 6.49%
program update
Genomma Lab Internacional Announces Third Dividend Payment - October 27, 2022 Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange...
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.56%
H: 0.84%
C: -0.59%
MOR | $17.96 -0.5% 72K
|
Health Technology
|
| O: -3.82%
H: 6.9%
C: 6.49%
MIRM | $23.7 0.55% 110K
|
Health Technology
|
| O: 0.48%
H: 2.41%
C: -7.81%
ARGX | $357.65 -0.21% 93K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -3.71%
payment
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.